Arixtra and Piperacillin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Arixtra (fondaparinux sodium) and Piperacillin (piperacillin sodium). Common drug interactions include pulmonary embolism among females and rhabdomyolysis among males.

The phase IV clinical study analyzes what interactions people have when they take Arixtra and Piperacillin. It is created by eHealthMe based on reports of 24 people who take the same drugs from the FDA, and is updated regularly.

What is Arixtra?

Arixtra has active ingredients of fondaparinux sodium. It is often used in deep venous thrombosis. eHealthMe is studying from 9,830 Arixtra users. Check the latest studies of Arixtra.

What is Piperacillin?

Piperacillin has active ingredients of piperacillin sodium. eHealthMe is studying from 5,597 Piperacillin users. Check the latest studies of Piperacillin.

On Jul, 15, 2026

24 people who take Arixtra and Piperacillin together, and have interactions are studied.

Arixtra and Piperacillin drug interactions.

What are the common drug interactions of Arixtra and Piperacillin, by gender? *:

female:

Pulmonary embolism (blockage of the main artery of the lung)
Septic shock (shock due to blood infection)
Haemoglobin decreased
Melaena (the passage of black, tarry stools)
Rectal haemorrhage (bleeding from anus)
Red blood cell count decreased
Respiratory failure (inadequate gas exchange by the respiratory system)
Anaemia (lack of blood)
Bronchial haemorrhage (bleeding in bronchia)
Bronchopulmonary aspergillosis (lung disorder caused by aspergillus fungi)

male:

Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
Renal failure acute (rapid kidney dysfunction)
Dermatitis exfoliative (widespread scaling of the skin, often with itching (pruritus), skin redness (erythroderma), and hair loss)
Diarrhoea
Dyspnoea (difficult or laboured respiration)
Eosinophilia (eosinophil count in the peripheral blood exceeds)
Haematocrit decreased
Heparin-induced thrombocytopenia
Hepatocellular injury (liver injury)
Interstitial lung disease

What are the common drug interactions of Arixtra and Piperacillin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Drug rash with eosinophilia and systemic symptoms (adverse drug reactions with rash)
Cough
Dermatitis exfoliative (widespread scaling of the skin, often with itching (pruritus), skin redness (erythroderma), and hair loss)
Eosinophilia (eosinophil count in the peripheral blood exceeds)
Hepatocellular injury (liver injury)
Interstitial lung disease
Myopericarditis (disease caused by inflammation of the myocardium (muscle of the heart wall) and/or the pericardium)
Pyrexia (fever)
Rash erythematous (redness of the skin)
Rash maculo-papular (red area on the skin that is covered with small confluent bumps)

40-49:

n/a

50-59:

n/a

60+:

Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
Renal failure acute (rapid kidney dysfunction)
Respiratory failure (inadequate gas exchange by the respiratory system)
Anaemia (lack of blood)
Bronchial haemorrhage (bleeding in bronchia)
Bronchopulmonary aspergillosis (lung disorder caused by aspergillus fungi)
C-reactive protein increased
Candiduria (candida in urine)
Cardiovascular disorder (heart diseases)
Citrobacter infection (infection by citrobacter (bacteria))

* Approximation only. Some reports may have incomplete information.

Do you take Arixtra and Piperacillin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously